StockData
BrainStorm Cell Therapeutics Inc. logo

BrainStorm Cell Therapeutics Inc. (BCLI) income statement

BCLIOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 0/30
$0.77−0.01 (-1.17%)

Close on Oct 19, 2026Market cap $8.50MP/E –Yield –

BrainStorm Cell Therapeutics Inc. financial ratios

See a number that looks wrong?